Zee’s SEBI order remains on appeal after SAT warrant stay

Zee Entertainment Enterprises Limited faces a Rs 30 lakh Securities and Exchange Board of India penalty and a two-month restraint on securities-market access under a 31 July 2026 order. Zee appealed to the Securities Appellate Tribunal, which on 14 August 2026 stayed the directions only to enable a preferential warrant allotment; the main appeal remains pending.

What did SEBI order against Zee?

SEBI imposed a Rs 30 lakh penalty on Zee in an order dated 31 July 2026 that was served on 1 August 2026. The order also restrained Zee from accessing the securities market for two months from the date of the order, according to the company’s disclosure. SEBI additionally imposed penalties and market-access restraints on a current key management personnel, or KMP, and a former director.

The order followed a set of show-cause notices, or SCNs, concerning alleged regulatory violations in prior periods. An SCN dated 7 August 2025 concerned an alleged lien over a Zee property in financial year 2018-19. A further SCN dated 16 January 2026 concerned inter-corporate deposits from earlier years, which Zee said had already been fully provided for in its accounts.

A third SCN dated 12 February 2026 alleged violations connected with film advances, related-party transactions, and disclosure and control matters from earlier periods. Zee said it had furnished detailed replies denying the allegations in the August 2025 and January 2026 SCNs. For the February 2026 SCN, Zee said it believed it had sufficient evidence to respond appropriately and would file a detailed response in due course.

Did SAT remove Zee’s market-access restraint?

No, SAT did not finally remove Zee’s market-access restraint in the disclosed order. Zee said SAT stayed the directions against it only for the limited purpose of allowing the preferential issue of warrants to be completed. The 14 August 2026 order was interim relief while the substantive appeal remained pending before SAT.

The filing does not say that SAT set aside SEBI’s 31 July 2026 order on its merits. It says Zee sought a stay of the directions in the order and other urgent interim relief, and SAT allowed the specific warrant allotment. Zee said, based on its legal assessment, that it believes it has a strong case on merits before SAT, but this remains the company’s view rather than a final tribunal finding.

The disclosure also records an earlier and separate SAT outcome involving a current KMP. On 30 October 2023, SAT set aside SEBI’s ex-parte interim order dated 12 June 2023 and confirmatory order dated 14 August 2023 against that KMP. SAT’s 2023 order recorded that SEBI would continue its investigation, while the August 2026 relief relates to Zee’s warrant allotment.

What preferential warrant issue did the limited stay enable?

The limited stay enabled Zee to allot warrants under a promoter-group preferential issue approved by its board on 1 July 2026 and by shareholders at an extraordinary general meeting on 31 July 2026. The proposal covered up to 24,94,85,563 warrants, each exchangeable for one fully paid equity share, at an issue price of Rs 126 per warrant.

The aggregate approved issue size was Rs 3,143.5 crore. Each warrant carried a subscription price of Rs 31.5 and an exercise price of Rs 94.5, so the subscription amount represented 25% of the warrant issue price. Zee identified the proposed allottee as a promoter-group entity.

During the quarter ended 30 September 2026, Zee received Rs 735.5 crore as warrant subscription money and allotted 23,35,07,071 warrants. The warrant holders may seek conversion in one or more tranches within a maximum of 18 months from allotment, subject to payment of the Rs 94.5 exercise price. This was the preferential transaction for which Zee said SAT granted limited relief.

What other SEBI matters has Zee disclosed?

Zee disclosed that it had filed settlement applications under the SEBI Settlement Proceedings Regulations, 2018, in relation to the SCN matters, but SEBI rejected those applications. The company said the applications were filed to avoid protracted litigation. Zee also said its authorised representative attended SEBI hearings related to the August 2025 and January 2026 SCNs.

Zee’s board-appointed Independent Investigation Committee submitted its report on 8 October 2024 after a fact-checking exercise supported by external experts. According to Zee, the board took the report on record and noted that transactions under review were against consideration for valid goods and services received. The filing does not state that the internal report settled SEBI’s proceedings.

The company also disclosed a Ministry of Corporate Affairs, or MCA, notice received after 30 September 2026 under Sections 210(1)(a) and 210(1)(c) of the Companies Act, 2013. Zee said the notice sought certain information and that it was in the process of making its submission. Management told the board that it did not expect a material adverse impact on Zee’s operations or financial results from the matters described.

Conclusion

Zee’s regulatory position remains unresolved because its appeal against SEBI’s 31 July 2026 order is pending before SAT. The Rs 30 lakh penalty and the two-month market-access restraint form part of that order, while SAT’s 14 August 2026 relief was confined to permitting the preferential warrant allotment. That allotment produced Rs 735.5 crore of subscription proceeds during the quarter ended 30 September 2026.

The next disclosed event to watch is SAT’s adjudication of Zee’s main appeal. Separately, holders of the 23,35,07,071 allotted warrants have up to 18 months from allotment to seek conversion by paying the Rs 94.5 exercise price, and Zee is preparing its response to the MCA information notice received after 30 September 2026.